NCT01276119View on ClinicalTrials.gov

The First Clinical Study to Test Safety, Blood Levels and Other Effects of CDP6038 in Healthy Males

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Pharmacokinetics
Interventions
BIOLOGICAL

CDP6038

100 mg/mL solution for injection Single infusion over 60 minutes

BIOLOGICAL

CDP6038

100 mg/mL solution for injection Single infusion over 120 minutes

BIOLOGICAL

CDP6038

100 mg/mL solution for injection Single sc injection

OTHER

Placebo

0.9% sodium chloride for injection Single infusion over 60 minutes

OTHER

Placebo

0.9% sodium chloride for injection Single infusion over 120 minutes

OTHER

Placebo

0.9% sodium chloride for injection Single sc injection

Trial Locations (1)

Unknown

Berlin

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY